Home › Funds › Birchview Capital, LP › CAMP

Birchview Capital, LP position in CAMP

CAMP4 THERAPEUTICS CORP · Health Care

Birchview Capital, LP reported holding 120,000 shares of CAMP (CAMP4 THERAPEUTICS CORP) in its Q3 2026 13F filing — a position valued at US$485K, representing 0.29% of its reported portfolio and ranking #50 among its reported holdings. Birchview Capital, LP has disclosed CAMP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)120.00K sh
Reported value held$484.80K
Portfolio Weight0.29%
First reportedQ2 2026
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's CAMP position evolved

Birchview Capital, LP first disclosed a stake in CAMP in Q2 2026 at 120,000 shares (US$524K). Across 2 filings, Birchview Capital, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 120,000 shares valued at US$485K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 120.00K $524.40K New
Q3 2026 120.00K $484.80K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAMP and 13F data

CAMP (CAMP4 THERAPEUTICS CORP) is a Health Care company. 37 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$22.6M), Stonepine Capital Management, LLC (US$11.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAMP

All CAMP fund holders →

FAQ

How long has Birchview Capital, LP held CAMP?

Birchview Capital, LP has disclosed CAMP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Birchview Capital, LP's current position in CAMP?

As of Q3 2026, Birchview Capital, LP holds 120.00K shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $484.80K, representing 0.29% of its reported portfolio and ranking #50.

Has Birchview Capital, LP been buying or selling CAMP?

In the latest 13F filing (Q3 2026), Birchview Capital, LP held unchanged its position in CAMP.

Which other funds hold CAMP?

Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, Stonepine Capital Management, LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.